Skip to content

SOPHARMA

Active Public limited companyfounded 2001active for 24 yearsJezus Eiklaan 2A, 3080 TervurenKBO/BCE: BE 0476.391.546 #1 company by total assets in Tervuren, Wholesale and retail trade sector

Timeline

51 events since 2001

The 2026 accounts are due by 31-07-2027.

2026
reappointed as managing director acts as permanent representative · General meeting of 30-06-20264 points ▸
  • General meeting of 30-06-2026
  • reappointed as director
  • acts as permanent representative
  • reappointed as managing director

Open the deed in the Belgian Official Gazette

Annual accounts 2025 filed NBBabbreviated format · 1 day before the deadline
2025
Liquidity more than doubled current ratio 14.29 The current ratio rises from 4.95 to 14.29.
Equity above €100m equity €167.3m ▲213% After 14 profitable years in a row, equity reaches €167.3m.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0476391546
Capital increase · Resignations & appointmentsThe capital rose from €45,057,000 to €47,452,056.48, with 256 new shares · The capital rose from €47,452,056.48 to €52,796,681.99 · is a shareholder · General meeting of 30-06-20259 points ▸
  • General meeting of 30-06-2025
  • The capital was increased by €2,395,056.48
  • Incorporation, 19-06-1989
  • The capital is €47,452,056.48, divided into 5,072 shares
  • The capital was increased by €5,344,625.51
  • is a shareholder
  • Article 5 of the articles of association amended
  • Article 30 of the articles of association amended
  • Power of attorney granted to
  • The deed holds 11 more points.

Open the deed in the Belgian Official Gazette

Merger: SOPHARMA takes over SOLOBACapital increase of €583.95 to €45,057,000 · The capital rose from €45,056,416.05 to €45,057,000 · The company holds all the shares of SOLOBA · General meeting of 30-06-20258 points ▸
  • General meeting of 30-06-2025
  • Operation treated as a merger by absorption
  • The company holds all the shares of SOLOBA
  • The operation takes effect in the accounts on 01-01-2025
  • The capital was increased by €583.95
  • Article 5 of the articles of association amended
  • Power of attorney granted to
  • Discharge granted to
  • The deed holds 21 more points.

Open the deed in the Belgian Official Gazette

Merger: SOPHARMA takes over Excelsus NVIssue of 3,047 shares · General meeting of 30-06-20254 points ▸
  • General meeting of 30-06-2025
  • The operation takes effect in the accounts on 01-01-2025
  • Article 5 of the articles of association amended
  • Power of attorney granted to
  • The deed holds 22 more points.

Open the deed in the Belgian Official Gazette

Merger proposal: SOPHARMA takes over SOLOBA and EXCELSUS acts as permanent representative · The company holds all the shares of SOLOBA · holds 100% of the shares11 points ▸
  • Operation treated as a merger by absorption
  • Merger by absorption
  • The capital is €32,789,801.85, divided into 49,066 shares
  • The company holds all the shares of SOLOBA
  • The capital is €16,550,000, divided into 1,769 shares
  • holds 100% of the shares
  • The capital was increased by €28,506,416.05
  • holds 4,816 shares (100%)
  • acts as permanent representative
  • The operation takes effect in the accounts on 01-01-2025
  • The capital was increased by €583.95
  • The deed holds 18 more points.

Open the deed in the Belgian Official Gazette

Merger proposal: SOPHARMA takes over EXCELSUS acts as permanent representative · holds 100% of the shares · Capital increase of €45,056,416.0513 points ▸
  • is in office as director
  • is in office as director
  • The capital is €16,550,000, divided into 1,769 shares
  • holds 100% of the shares
  • is in office as sole director
  • acts as permanent representative
  • The capital was increased by €45,056,416.05
  • The operation takes effect in the accounts on 01-01-2025
  • Real estate, EXCELSUS
  • Membership rule,
  • Merger by absorption
  • The capital is €63,000, divided into 630 shares
  • is a shareholder
  • The deed holds 18 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2024 filed PDFabbreviated format · 66 days before the deadline
2024
Liquidity more than doubled current ratio 4.95 The current ratio rises from 2.27 to 4.95. Short-term debt falls from €728,870 to €494,248.
Annual accounts 2023 filed PDFabbreviated format · 36 days before the deadline
2023
Annual accounts 2022 filed PDFabbreviated format · 47 days before the deadline
2022
Annual accounts 2021 filed PDFabbreviated format · 61 days late
2021
Liquidity more than doubled current ratio 1.98 The current ratio rises from 0.95 to 1.98. Short-term debt falls from €766,057 to €766,049.
Equity above €50m equity €50.0m ▲5.9% After 10 profitable years in a row, equity reaches €50.0m.
Annual accounts 2020 filed PDFabbreviated format · 31 days late
Environmental permit granted Build or rebuild, Demolish · decided by Tervuren
2020
Highest result from 2006 to 2025 net €29.3m ▲11,301% The net result of €29.3m is the highest of those years.
Equity above €25m equity €47.2m ▲3,008% After 9 profitable years in a row, equity reaches €47.2m.
2 directors reappointedExcelsus NV and (managing director) · , and act as permanent representatives · General meeting of 08-05-20208 points ▸
  • General meeting of 08-05-2020
  • Excelsus NV reappointed as director
  • reappointed as director
  • acts as permanent representative
  • acts as permanent representative
  • acts as permanent representative
  • Board meeting of 08-05-2020
  • reappointed as managing director

Open the deed in the Belgian Official Gazette

Capital increase of €16,400,000 to €16,550,000The capital rose from €150,000 to €16,550,000, with 1,619 new shares · Excelsus (director) and (director) resign · appointed as statutory auditor · General meeting of 17-07-202013 points ▸
  • General meeting of 17-07-2020
  • The capital is €150,000, divided into 150 shares
  • Excelsus resigns as director
  • resigns as director
  • Discharge granted to Excelsus
  • Discharge granted to
  • is in office as sole director
  • appointed as statutory auditor
  • holds 16,319 shares
  • holds 1,200 shares
  • The capital was increased by €16,400,000
  • The capital is €16,550,000, divided into 1,769 shares
  • Article 5 of the articles of association amended
  • The deed holds 9 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2019 filed PDFabbreviated format · 25 days before the deadline
2019
Annual accounts 2018 filed PDFabbreviated format · 12 days before the deadline
2018
Annual accounts 2017 filed PDFabbreviated format · 28 days late
2017
Equity above €1m equity €1.1m ▲19.2% After 6 profitable years in a row, equity reaches €1.1m.
Annual accounts 2016 filed PDFabbreviated format · 19 days before the deadline
2016
Annual accounts 2015 filed PDFabbreviated format · 22 days late
2015
Annual accounts 2014 filed PDFabbreviated format · 22 days before the deadline
2014
Equity above €500,000 equity €573,173 ▲50.4% After 3 profitable years in a row, equity reaches €573,173.
Registered office moved within TervurenThe registered office moved from Jezus Eiklaan 2, 3080 Tervuren to Jezus Eiklaan 2A, 3080 Tervuren · Board meeting of 01-10-20132 points ▸
  • Board meeting of 01-10-2013
  • The registered office moved to Jezus Eiklaan 2A, 3080 Tervuren

Open the deed in the Belgian Official Gazette

Annual accounts 2013 filed PDFabbreviated format · 27 days before the deadline
2 directors reappointed (managing director) and Excelsus NV (chair of the board) · , and act as permanent representatives · General meeting of 09-05-20149 points ▸
  • General meeting of 09-05-2014
  • reappointed as director
  • Excelsus NV reappointed as director
  • acts as permanent representative
  • acts as permanent representative
  • acts as permanent representative
  • Board meeting of 09-05-2014
  • reappointed as managing director
  • Excelsus NV reappointed as chair of the board

Open the deed in the Belgian Official Gazette

2013
Annual accounts 2012 filed PDFabbreviated format · 30 days before the deadline
2012
Back to profit net €97,222 The net result is €97,222, after 5 loss-making years.
Annual accounts 2011 filed PDFabbreviated format · 39 days before the deadline
Amendment of the articlesGeneral meeting of 22-12-20113 points ▸
  • General meeting of 22-12-2011
  • Article 15 of the articles of association amended
  • Power of attorney granted to
  • The deed holds 3 more points.

Open the deed in the Belgian Official Gazette

2011
Weakest financial year net -€33,688 The net result drops to -€33,688, the lowest from 2006 to 2025. It recovers the following year.
Annual accounts 2010 filed PDFabbreviated format · 40 days before the deadline
2010
Annual accounts 2009 filed PDFabbreviated format · 18 days before the deadline
2009
Annual accounts 2008 filed PDFabbreviated format · 53 days before the deadline
3 directors appointed, 3 resignations (managing director), and resign · (managing director), Excelsus NV and appointed · , and act as permanent representatives · General meeting of 02-01-200910 points ▸
  • General meeting of 02-01-2009
  • resigns as managing director
  • resigns as director
  • resigns as director
  • appointed as managing director
  • Excelsus NV appointed as director
  • appointed as director
  • acts as permanent representative
  • acts as permanent representative
  • acts as permanent representative

Open the deed in the Belgian Official Gazette

2008
Annual accounts 2007 filed PDFabbreviated format · 50 days before the deadline
2007
Annual accounts 2006 filed PDFabbreviated format · 49 days before the deadline
2006
Annual accounts 2005 filed PDFabbreviated format
2005
Annual accounts 2004 filed PDFabbreviated format
2004
Annual accounts 2003 filed PDFabbreviated format
2003
Annual accounts 2002 filed PDFabbreviated format
2002
First establishment APOTHEEK - PHARMACIE, Jezus Eiklaan 2 A, Tervuren
2001
Incorporation published on 03-01-2002

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

SOPHARMA was incorporated on 20 December 2001.1 In 2014 the registered office moved within Tervuren.2 Between 2020 and 2025 the capital was increased 3 times, most recently to €52.8m.345 In 2025 the company absorbed EXCELSUS and SOLOBA by merger.64 The board currently has 2 members.7

  1. 1KBO register
  2. 2Belgian Official Gazette, 30-10-2014
  3. 3Belgian Official Gazette, 04-08-2020
  4. 4Belgian Official Gazette, 22-07-2025
  5. 5Belgian Official Gazette, 22-07-2025
  6. 6Belgian Official Gazette, 22-07-2025
  7. 7Belgian Official Gazette, 02-10-2026

Mentions of companies taken over

EXCELSUS, the company SOPHARMA took over in the merger of 30-06-2025, is named in 23 deeds.
Show the 10 newest deeds

Show all 23 deeds

SOLOBA, the company SOPHARMA took over in the merger of 30-06-2025, is named in 19 deeds.
Show the 10 newest deeds

Show all 19 deeds

Next steps